Biotech

All Articles

James Wilson leaving Penn to release pair of brand new biotechs

.After more than 30 years, genetics therapy trendsetter James Wilson M.D., Ph.D., is actually leavin...

3 biotechs make an effort to defeat the summer warmth by shedding team

.As biotechs seek to transform a fresh page in August, a minimum of 3 providers have dropped staff i...

venBio lifts $528M for 5th life sciences VC fund

.Veteran venture capital firm venBio has raised yet another half a billion bucks to purchase biotech...

Otsuka spends $800M for Jnana and its clinical-stage PKU medication

.Otsuka Drug has actually picked up Boston-based Jnana Rehabs for $800 thousand so the Oriental biot...

FibroGen lays off 75% of US staff as property fails 2 even more trials

.FibroGen is significantly restructuring its company, giving up 75% of its U.S. personnel as well as...

Tracon winds down weeks after injectable PD-L1 prevention neglect

.Tracon Pharmaceuticals has chosen to wind down procedures weeks after an injectable invulnerable ga...

Ideaya bags alternative on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M reduction on neglected epilepsy medication, touts FDA run

.Our team currently recognize that Takeda is planning to discover a course to the FDA for epilepsy m...

VBI Vaccinations declare bankruptcy, seeks resource purchase

.Immunology biotech VBI Injections is diverting dangerously near the moment of truth, along with str...

Celldex anti-cKIT antibody minimize hives in yet another phase 2 study

.It is actually not easy to muscle in on a space as affordable as immunology, however Celldex Therap...